Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Carter

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Family Practice|August 1, 1986
Erythromycin in the treatment of acute bronchitis in a community practiceF X Brickfield, W H Carter, R E Johnson
Pediatrics|May 23, 2001
Obstructive nephropathy in children: long-term progression after relief of posterior urethral valveK S Roth, W H Carter, J C Chan
Cancer Detection and Prevention|December 29, 2000
17 alpha androstenediol inhibition of breast tumor cell proliferation in estrogen receptor-positive and -negative cell linesP N Huynh, W H Carter, R M Loria
Cancer|March 4, 2000
Despite limited data, coexistent lobular carcinoma in situ should not be a contraindication to breast conservation for women with invasive breast carcinomaH D Bear, W H Carter, M M Grimes
The Journal of Pediatrics|August 1, 1996
Final report of the Growth Failure in Children with Renal Diseases StudyB H Brouhard, J C Chan, W H Carter
Biometrics|September 1, 1980
Survival analysis of drug combinations using a hazards model with time-dependent covariatesD M Stablein, W H Carter, G L Wampler
Analytical Chemistry|September 1, 1971
Countercurrent distribution as a tool for purification of hypothalamic hormones on a preparative scaleA V Schally, R M Nair, W H Carter
Biometrics|September 1, 1983
Confidence regions for constrained optima in response-surface experimentsD M Stablein, W H Carter, G L Wampler
Cancer|August 1, 1984
Solid tumor models for the assessment of different treatment modalities. XXII. The alternate utilization of radiotherapy and chemotherapyW B Looney, H A Hopkins, W H Carter
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1983
Sensitized (T6 X RFM)F1 donor B cells are engrafted and synthesize antibodies without further antigenic stimulation in RFM recipients with allogenic host-vs-graft diseaseR C Hard, W H Carter, P H Bick
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Family Practice|August 1, 1986
Erythromycin in the treatment of acute bronchitis in a community practiceF X Brickfield, W H Carter, R E Johnson
Pediatrics|May 23, 2001
Obstructive nephropathy in children: long-term progression after relief of posterior urethral valveK S Roth, W H Carter, J C Chan
Cancer Detection and Prevention|December 29, 2000
17 alpha androstenediol inhibition of breast tumor cell proliferation in estrogen receptor-positive and -negative cell linesP N Huynh, W H Carter, R M Loria
Cancer|March 4, 2000
Despite limited data, coexistent lobular carcinoma in situ should not be a contraindication to breast conservation for women with invasive breast carcinomaH D Bear, W H Carter, M M Grimes
The Journal of Pediatrics|August 1, 1996
Final report of the Growth Failure in Children with Renal Diseases StudyB H Brouhard, J C Chan, W H Carter
Biometrics|September 1, 1980
Survival analysis of drug combinations using a hazards model with time-dependent covariatesD M Stablein, W H Carter, G L Wampler
Analytical Chemistry|September 1, 1971
Countercurrent distribution as a tool for purification of hypothalamic hormones on a preparative scaleA V Schally, R M Nair, W H Carter
Biometrics|September 1, 1983
Confidence regions for constrained optima in response-surface experimentsD M Stablein, W H Carter, G L Wampler
Cancer|August 1, 1984
Solid tumor models for the assessment of different treatment modalities. XXII. The alternate utilization of radiotherapy and chemotherapyW B Looney, H A Hopkins, W H Carter
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1983
Sensitized (T6 X RFM)F1 donor B cells are engrafted and synthesize antibodies without further antigenic stimulation in RFM recipients with allogenic host-vs-graft diseaseR C Hard, W H Carter, P H Bick
Pageof 12